Breeze Meds Review
Best for: compounded GLP-1 access with named prescribers and 4-pharmacy network
Breeze Meds is a Georgia-based telehealth provider offering compounded semaglutide ($199/mo), tirzepatide ($399/mo), and NAD+ ($169/mo) across all 50 states. LegitScript certified; named medical team (Dr. Ana Lisa Carr MD, Dr. Kelly Tenbrink MD) and a 4-pharmacy compounding network (Belmar, Strive, Epiq Scripts, Casa Pharma Rx) via Lion MD.
What the monthly price covers
Medication
Included
Provider visits
Not disclosed
Shipping
Included
Lab work
Not disclosed
Coaching
Not disclosed
No insurance needed · Vetted by our editors
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
The Bottom Line
Breeze Meds is a solid telehealth option with balanced features and pricing.
Breeze Meds at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $199/mo
- What's included
- Medication · Shipping
- Availability
- All 50 states
- FDA status
- No FDA warning letter on record
How we scored Breeze Meds
Each dimension is scored algorithmically from Breeze Meds’s real pricing, drugs offered, verification status, and disclosed inclusions — using the same six-dimension framework we apply to every provider.
Value25%
6.7/10At $199/mo, Breeze Meds runs about 17% above the $170 median for GLP-1 providers.
Effectiveness25%
8.1/10Breeze Meds offers both semaglutide and tirzepatide — the two GLP-1 molecules with the strongest published weight-loss trial outcomes. An oral/needle-free option is offered for patients who avoid injections.
User Experience15%
7.0/10Online intake and platform experience; 6 platform features disclosed.
Trust & Safety15%
7.9/10Core details confirmed by our editors; no FDA warning letters on file; dispenses through an accredited compounding pharmacy (last checked 2026-06-03).
Accessibility10%
8.1/10Breeze Meds treats patients in all 50 states.
Support10%
5.7/10Breeze Meds provides standard clinician follow-up; no extended coaching or community program is disclosed.
How we verified this Breeze Meds review
Last checked 2026-06-03- Confirmed current pricing across 4 dose/plan tiers
- Confirmed availability in all 50 states
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the public intake/checkout flow on the provider's site
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records — see the sources below. Editorial confidence in this data: medium.
GLP-1 medications Breeze Meds offers
Tap any medication to read our plain-English guide — how it works, dosing, side effects, and what the trials found.
Peptides Breeze Meds offers
Beyond GLP-1s, Breeze Meds also offers these peptides — tap any for our evidence-based guide.
Pricing
Ready to get started?
Plans and promotions change often — check Breeze Meds's current pricing and active discounts before you decide.
What we like
- Available in all 50 states
- LegitScript Certified
- Publicly named medical team: Dr. Ana Lisa Carr, MD and Dr. Kelly Tenbrink, MD
- Four named 503A pharmacy partners: Belmar, Strive, Epiq Scripts, and Casa Pharma Rx
- Semaglutide and tirzepatide offered in both injectable and oral forms
- No FDA warning letters or litigation on record
Watch-outs
- Shares the same clinician network and pharmacies as Care Bare Rx and Synergy Rx — three storefronts on one operation, not independent providers
- Compounded medications are not FDA-approved
- Compounded vs. brand-name sourcing is unclear on the product pages
- Terms of Service page returns a 404 (only the Privacy Policy is present)
- Insurance acceptance isn't clearly disclosed beyond FSA/HSA eligibility
Breeze Meds: a Georgia compounding storefront with a named medical team
Breeze Meds is a telehealth brand run by Breezemeds, LLC, a Delaware company operating out of Marietta, Georgia. It sells compounded semaglutide, tirzepatide, and NAD+ to patients in all 50 states, and it does two things most cash-pay compounding shops won't: it publishes the actual doctors behind the prescriptions and it lists every pharmacy that fills them. If you want to know exactly who is signing off on your medication and where it's coming from, that transparency is the real reason to look here. The catch — and it's a meaningful one — is that Breeze Meds isn't quite the independent operation it appears to be.
What you actually pay
Pricing is straightforward and runs on a flat monthly model: $199 a month for injectable compounded semaglutide, with tirzepatide priced higher, and oral versions of both also on the menu at their own rates. The medication and shipping are bundled into that number, so there's no surprise pharmacy charge stacked on top. For context, $199 sits a bit above the category median of $170 a month, so Breeze Meds is not the cheapest compounded option out there — you're paying a small premium, and the question is whether the named clinicians and disclosed pharmacy network are worth it to you.
Breeze Meds does not appear to run a discounted first-month teaser rate, so the price you start at is roughly the price you keep paying. It advertises free shipping and notes that purchases are FSA/HSA eligible, which can soften the cost if you have a tax-advantaged health account.
The medications and how they're dispensed
Everything Breeze Meds sells is compounded, not brand-name. That's the important distinction to understand before you order: compounded semaglutide and tirzepatide are mixed by a pharmacy rather than manufactured and FDA-approved like Wegovy, Ozempic, or Zepbound. Compounded drugs are legal to prescribe but are not reviewed by the FDA for safety, effectiveness, or quality, and Breeze Meds' product pages don't always make the compounded-versus-brand distinction obvious — so go in knowing you're buying a compounded formulation.
The unusual part is the pharmacy side. Rather than relying on a single mystery compounder, Breeze Meds names a four-pharmacy network — Belmar, Strive, Epiq Scripts, and Casa Pharma Rx — coordinated through a clinical group called Lion MD. Offering both injectable and oral forms of each drug gives needle-averse patients a real alternative, which not every compounding provider bothers to do.
The differentiator: it tells you who and where
Most cash-pay compounding sites hide their clinicians and their pharmacy behind a generic 'licensed providers' line. Breeze Meds does the opposite. It publicly names its prescribers — Dr. Ana Lisa Carr, MD and Dr. Kelly Tenbrink, MD — down to their NPI numbers, and it lists all four compounding pharmacies by name. It also displays a LegitScript certification, the screening program that vets online pharmacies and is required to advertise this category on Google. Taken together, that's more verifiable detail than the typical competitor offers, and it's the single best argument for choosing Breeze Meds.
The part the marketing doesn't mention: it's one of three storefronts
Here's what our verification turned up, and it's the most important thing on this page. Breeze Meds shares its exact clinician team and its exact four pharmacies with two other brands — Care Bare Rx and Synergy Rx. Same doctors, same NPI numbers, same compounders. In practice these are three white-labeled storefronts sitting on top of one underlying telehealth-and-compounding operation, not three independent providers competing on quality. If you're price-shopping across all three thinking you're comparing different companies, you're not — you're comparing three front-ends to the same back office. That doesn't make Breeze Meds bad, but it should reset your expectations about what 'shopping around' between them gets you.
Who it's for — and who should skip it
Breeze Meds is a reasonable fit if transparency matters to you and you're comfortable with compounded medication: you can see the doctors, the pharmacies, and the LegitScript seal, and it ships nationwide with no brand-name premium. It's also worth a look if you want an oral option instead of injections.
- Consider it if: you want named, lookup-able prescribers and a disclosed pharmacy network, you're fine with compounded (non-FDA-approved) drugs, or you specifically want an oral GLP-1 alternative.
- Skip it if: you want brand-name Wegovy, Ozempic, Mounjaro, or Zepbound (Breeze Meds doesn't sell them), you're hunting for the lowest possible price (it runs above the category median), or you want to comparison-shop genuinely independent providers — Care Bare Rx and Synergy Rx are the same operation.
Trust, safety, and the loose ends
On the positive side, Breeze Meds carries no FDA warning letters and no litigation on record as of our review, its medical team and pharmacies are verifiable, and the LegitScript certification is a real screening signal. Those are genuine trust markers in a category full of anonymous sellers.
On the other side, a few things keep this from being a clean bill of health. The Terms of Service page returns a 404 — only a Privacy Policy is live — which is a sloppy gap for a company handling prescriptions and your money. Insurance handling isn't clearly spelled out beyond FSA/HSA eligibility, and the product pages don't consistently clarify the compounded-versus-brand sourcing. And the white-label cluster means the 'independent provider' framing is, at best, incomplete. You can read more about how we weigh these signals in our scoring methodology.
Bottom line
Breeze Meds earns points for doing what most compounding storefronts won't — naming its doctors, listing its pharmacies, and showing a LegitScript seal — and that transparency, plus all-50-states access and an oral option, makes it a credible choice at $199 a month if you're comfortable with compounded medication. Just go in with two facts straight: everything here is compounded and not FDA-approved, and Breeze Meds is one of three identical storefronts, not a standalone provider. Confirm the current price, the pharmacy your order ships from, and the refund terms before you commit.
Worth pricing against RNK Health ($197/month) and Care Bare Rx ($199/month) before you commit — both sit close to Breeze Meds on cost and formulation.
Ready to start with Breeze Meds?
Starting at $199/month. See current pricing and start your free consultation.
Breeze Meds might not be your best fit if…
We rank editorially, so here’s where a different provider we track may serve you better.
Alternatives to Breeze Meds
Enhance MD
Best for: lab-monitored compounded GLP-1 with mandatory video visit
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this Breeze Meds review:
Sources & methodology — as of July 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
Ready to start with Breeze Meds?
Starting at $199/month. See current pricing and start your free consultation.